メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
渡辺 宏久
医学部・脳神経内科学
h-index
8305
被引用数
48
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1997 …
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(252)
類似のプロファイル
(6)
フィンガープリント
Hirohisa Watanabeが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Neuroscience
Alzheimer's Disease
15%
Amyotrophic Lateral Sclerosis
77%
Androgen Receptor
11%
Ataxia
9%
Basal Ganglia
15%
Brain Network
20%
CAG Repeat
10%
Cerebellum
13%
Cognitive Disorders
35%
Cognitive Function
12%
Corpus Callosum
8%
Corticobasal Degeneration
11%
Default Mode Network
12%
Diffusion Tensor Imaging
15%
Dysautonomia
10%
Electrical Brain Stimulation
12%
Essential Tremor
8%
Executive Functions
8%
Fractional Anisotropy
16%
Frontal Lobe
13%
Frontotemporal Dementia
19%
Functional Connectivity
31%
Functional Magnetic Resonance Imaging
28%
Gray Matter
11%
Hyposmia
6%
Independent Component Analysis
10%
Magnetic Resonance Imaging
22%
Magnetic Resonance Imaging
16%
Multiple Sclerosis
8%
Multiple System Atrophy
64%
Muscle Atrophy
28%
Nervous System Disorder
7%
Neurodegeneration
9%
Neurodegenerative Disorder
18%
Neuromelanin
9%
Parkinson's Disease
100%
Parkinsonism
10%
Peripheral Neuropathy
12%
Polyglutamine
11%
Polyneuropathy
9%
Posterior Cingulate
6%
Putamen
10%
Spinocerebellar Ataxia
9%
Spinocerebellar Ataxia Type-6
8%
Stereotypic Movement Disorder
15%
Subthalamic Nucleus
13%
Temporal Lobe
5%
Thalamus
6%
Tremor
7%
Voxel-Based Morphometry
18%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
14%
Alzheimer's Disease
6%
Amyotrophic Lateral Sclerosis
12%
Biological Marker
6%
Cognitive Defect
6%
Corticobasal Degeneration
11%
Diabetic Neuropathy
8%
Diagnosis
8%
Diffuse Lewy Body Disease
9%
Diffusion MRI
5%
Disease
13%
Edaravone
8%
Electrical Brain Stimulation
8%
Familial Amyloid Neuropathy
5%
Granuloma
5%
Heart Scintiscanning
8%
Intravenous Immunoglobulin Therapy
8%
Iodine 123
13%
Kennedy Disease
21%
Liver Transplantation
8%
Magnetic Resonance Imaging
20%
Muscle Strength
5%
Muscle Weakness
5%
Neurodegenerative Disorder
5%
Neurologic Disease
14%
Neurology
7%
Neuropathy
12%
Onset Age
6%
Orthostatic Stress
5%
Pain Assessment
6%
Parkinson's Disease
31%
Placebo
5%
Plummer-Vinson Syndrome
5%
Prevalence
5%
Progressive Supranuclear Palsy
8%
Rating Scale
5%
Sarcoidosis
8%
Shy-Drager Syndrome
18%
Speech Disorder
5%
Stereotypic Movement Disorder
5%
Subthalamic Nucleus
8%
Sympathetic Nerve
8%
Symptom
10%
Tongue
8%
Vasculitis
5%
Vocal Folds
6%
Voice Disorder
8%
Voxel-Based Morphometry
7%
Keyphrases
Amyotrophic Lateral Sclerosis
7%
Diabetic Neuropathy
8%
Fused in Sarcoma
8%
Hypokinetic Dysarthria
5%
Intravenous Immunoglobulin (IVIg)
5%
Intravenous Immunoglobulin Therapy
8%
Japanese Patients
8%
Japanese Society of Neurology
8%
MSA-P
7%
Multiple System Atrophy
8%
Muscle Strength
5%
Muscle Weakness
5%
Neurological Diseases
8%
Neurology
8%
Parkinson Patients
8%
Parkinson's Disease
5%
Severe Pain
7%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
8%
Wheelchair
7%
